The new strategy called Receptorchem offers the significant route for focused therapeutic transport. This depends on engineering compounds that selectively dock to receptors expressed on cancerous cells. Unlike https://agendabookmarks.com/story22080202/receptorchem-a-novel-approach-to-targeted-drug-delivery